Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Dubuisson

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Frontiers in Neurology|February 20, 2024
Editorial: Implementing new technologies for neuromuscular disordersNicolas Dubuisson, Kristl Claeys, Benedikt Schoser
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 25, 2017
Science is 1% inspiration and 99% biomarkersNicolas Dubuisson, Fabiola Puentes, Gavin Giovannoni, et al.
International Journal of Molecular Sciences|April 15, 2020
Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together?Michel Abou-Samra, Camille M Selvais, Nicolas Dubuisson, et al.
Acta Neurologica Belgica|May 26, 2020
Intravenous immunoglobulin-induced aseptic meningitis in a patient with Miller Fisher syndromeSofia Maldonado Slootjes, Antoine Guilmot, Nicolas Dubuisson, et al.
Acta Neurologica Belgica|September 3, 2021
SARS-CoV-2-associated Guillain-Barré syndrome in four patients: what do we know about pathophysiology?Antoine Guilmot, Sofia Maldonado Slootjes, Véronique Bissay, et al.
Acta Neurologica Scandinavica|January 19, 2019
Cerebrospinal fluid NCAM levels are modulated by disease-modifying therapiesMarkus Axelsson, Nicolas Dubuisson, Lenka Novakova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 16, 2018
Inclusion criteria used in trials of people with progressive multiple sclerosisNicolas Dubuisson, Monica Marta, Sharmilee Gnanapavan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 4, 2017
Disease modification in advanced MS: Focus on upper limb functionNicolas Dubuisson, David Baker, Alison Thomson, et al.
Cells|November 27, 2021
Walking down Skeletal Muscle Lane: From Inflammasome to DiseaseNicolas Dubuisson, Romain Versele, María A Davis-López de Carrizosa, et al.
International Journal of Molecular Sciences|December 23, 2022
Histological Methods to Assess Skeletal Muscle Degeneration and Regeneration in Duchenne Muscular DystrophyNicolas Dubuisson, Romain Versele, Chloé Planchon, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Frontiers in Neurology|February 20, 2024
Editorial: Implementing new technologies for neuromuscular disordersNicolas Dubuisson, Kristl Claeys, Benedikt Schoser
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 25, 2017
Science is 1% inspiration and 99% biomarkersNicolas Dubuisson, Fabiola Puentes, Gavin Giovannoni, et al.
International Journal of Molecular Sciences|April 15, 2020
Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together?Michel Abou-Samra, Camille M Selvais, Nicolas Dubuisson, et al.
Acta Neurologica Belgica|May 26, 2020
Intravenous immunoglobulin-induced aseptic meningitis in a patient with Miller Fisher syndromeSofia Maldonado Slootjes, Antoine Guilmot, Nicolas Dubuisson, et al.
Acta Neurologica Belgica|September 3, 2021
SARS-CoV-2-associated Guillain-Barré syndrome in four patients: what do we know about pathophysiology?Antoine Guilmot, Sofia Maldonado Slootjes, Véronique Bissay, et al.
Acta Neurologica Scandinavica|January 19, 2019
Cerebrospinal fluid NCAM levels are modulated by disease-modifying therapiesMarkus Axelsson, Nicolas Dubuisson, Lenka Novakova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 16, 2018
Inclusion criteria used in trials of people with progressive multiple sclerosisNicolas Dubuisson, Monica Marta, Sharmilee Gnanapavan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 4, 2017
Disease modification in advanced MS: Focus on upper limb functionNicolas Dubuisson, David Baker, Alison Thomson, et al.
Cells|November 27, 2021
Walking down Skeletal Muscle Lane: From Inflammasome to DiseaseNicolas Dubuisson, Romain Versele, María A Davis-López de Carrizosa, et al.
International Journal of Molecular Sciences|December 23, 2022
Histological Methods to Assess Skeletal Muscle Degeneration and Regeneration in Duchenne Muscular DystrophyNicolas Dubuisson, Romain Versele, Chloé Planchon, et al.
Pageof 3